University of MIchigan
Ann Arbor, Michigan, 48109, United States
NCT Number: NCT03223168
The purpose of this study is to assess for acute hemodynamic changes after implementation of noninvasive negative pressure ventilation (as compared with spontaneous respiration) in pediatric patients with Fontan failure using modern negative pressure ventilators
Looking for future studies?
Notify Me10 year and older
All sexes
Interventional
Not applicable
Ann Arbor, Michigan, 48109, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will receive Noninvasive negative pressure from the Hayek RTX ventilator for 30 minutes during diagnostic catheterization procedure.
Time frame: Baseline, 45 Minutes
Pulmonary artery wedge pressure will be measured in millimeters of mercury (mmHg) at baseline and completion of noninvasive negative pressure ventilation.
Time frame: Baseline, 45 Minutes
Change in pulmonary blood flow will be measured at baseline and completion of noninvasive negative pressure ventilation.
Time frame: Baseline, 45 Minutes
Systemic arterial saturation measures the amount of oxygen in the blood stream. Systemic arterial saturation will be registered at baseline and completion of noninvasive negative pressure ventilation.
Time frame: Baseline, 45 Minutes
Cardiac output will be measured in liters per minute at baseline and completion of noninvasive negative pressure ventilation
University of Michigan
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03303248
Cardiovascular Abnormalities, Cardiovascular Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT03564522
Cardiovascular Abnormalities, Cardiovascular Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT02752191
Pediatric Congenital Heart Disease
Los Angeles, California, United States
View Trial DetailsNCT06784440
Adult Congenital Heart Disease, Cardiovascular Abnormalities
Bologna, Italy
View Trial Details